Back
KalVista Pharmaceuticals Stock Price Chart
My #1 Coin is...
All the details are on the next page.
Buy
66
KALV
KalVista Pharmaceuticals
Last Price:
12.13
Seasonality Move:
-5.6%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KALV is experiencing slight selling pressure.
KalVista Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.31 | Buy |
| 20-day SMA: | 11.51 | Buy |
| 50-day SMA: | 12.14 | Sell |
| 200-day SMA: | 11.01 | Buy |
| 8-day EMA: | 11.65 | Buy |
| 20-day EMA: | 11.57 | Buy |
| 50-day EMA: | 11.93 | Buy |
| 200-day EMA: | 11.25 | Buy |
KalVista Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 56.49 | Buy |
| Chaikin Money Flow: | -66552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.95 - 11.95) | Buy |
| Bollinger Bands (100): | (11.02 - 14.04) | Sell |
KalVista Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for KalVista Pharmaceuticals Stock
Is KalVista Pharmaceuticals Stock a Buy?
- KalVista Pharmaceuticals share price is 12.13 while KALV 8-day simple moving average is 11.31, which is a Buy signal.
- The stock price of KALV is 12.13 while KalVista Pharmaceuticals 20-day SMA is 11.51, which makes it a Buy.
- KalVista Pharmaceuticals 50-day simple moving average is 12.14 while KALV share price is 12.13, making it a Sell technically.
- KALV stock price is 12.13 and KalVista Pharmaceuticals 200-day simple moving average is 11.01, creating a Buy signal.
KALV Technical Analysis vs Fundamental Analysis
Buy
66
KalVista Pharmaceuticals (KALV)
is a Buy
Is KalVista Pharmaceuticals a Buy or a Sell?
-
KalVista Pharmaceuticals stock is rated a Buy
The current KalVista Pharmaceuticals [KALV] share price is $12.13. The Score for KALV is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
KalVista Pharmaceuticals Stock Info
Market Cap:
511.74M
Price in USD:
12.13
Share Volume:
199.66K
KalVista Pharmaceuticals 52-Week Range
52-Week High:
16.88
52-Week Low:
7.21
Buy
66
KalVista Pharmaceuticals (KALV)
is a Buy
KalVista Pharmaceuticals Share Price Forecast
-
What is the KalVista Pharmaceuticals stock price today?
The KalVista Pharmaceuticals stock price is 12.13 USD today. -
Will KALV stock go up or go down?
KalVista Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is KalVista Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, KalVista Pharmaceuticals is not overvalued.
Is KalVista Pharmaceuticals Stock a Buy?
- KalVista Pharmaceuticals share price is 12.13 while KALV 8-day exponential moving average is 11.65, which is a Buy signal.
- The stock price of KALV is 12.13 while KalVista Pharmaceuticals 20-day EMA is 11.57, which makes it a Buy.
- KalVista Pharmaceuticals 50-day exponential moving average is 11.93 while KALV share price is 12.13, making it a Buy technically.
- KALV stock price is 12.13 and KalVista Pharmaceuticals 200-day simple moving average is 11.25, creating a Buy signal.
Fundamental Analysis of KalVista Pharmaceuticals
Is KalVista Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.40 per share, and an increase next year of $0.62 per share.
Technical Analysis of KalVista Pharmaceuticals
Should I short KalVista Pharmaceuticals stock?
- KALV Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting KalVista Pharmaceuticals is a Sell
- KalVista Pharmaceuticals Relative Strength Index (RSI) is 56.49, which suggest KalVista Pharmaceuticals is overbought
- The Bollinger Bands (25) for KalVista Pharmaceuticals is (10.95 - 11.95), which suggest KalVista Pharmaceuticals is a Sell
- The Bollinger Bands (100) for KalVista Pharmaceuticals is (11.02 - 14.04), which suggest KalVista Pharmaceuticals is a Sell
* KalVista Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.